AttoQuest
Mini-microscopes, massive impact – diagnostics and research at the single molecule level.
At a glance
-
Development stage
Scaling operations
-
Investment stage
Seed
-
UNSW affiliation
Spinout - staff led
-
Technology readiness level
TRL-5
-
Female led
Yes
AttoQuest develops advanced mini-microscopes for rapid, high-resolution microscopy.
Its flagship product, AttoBright, accelerates discoveries and enhances diagnostic precision for biomedical research and clinical applications. With 11 units already sold to leading labs in Australia, North America, and Europe, AttoQuest is poised to redefine global diagnostic capabilities.
-
AttoBright is a compact high-resolution mini-microscope that delivers fast and precise diagnostic insights at a fraction of the cost of traditional tools. This scalable technology enables rapid disease detection and single-molecule analysis, empowering pathologists and technicians, diagnostic assistants, and researchers alike.
Revenue is generated through direct sales, leasing, and service contracts, making advanced diagnostics accessible to a wider range of customers.
-
- Clinical diagnostics depend on centralised labs where tests can exceed AUD1,000 per analysis and results can be delayed for several days.
- Researchers face limited access to AUD700K+ microscopes that require training and expert use.
- These barriers constrain progress in both patient care and biomedical discovery.
-
- Hospitals
- Diagnostic labs
- Biomedical research institutions
-
- AUD700K in sales
- Australia Economic Accelerator Ignite grant for AUD500K
- Pilot project with hospitals to validate device performance
- Ongoing product-licensing discussions with a leading diagnostic company
- USD6 million in commercial contracts and partnerships, and two grants with ASX200 companies
Discover more UNSW spinouts
Search our catalogue of active spinouts and tech for license.